Over the coming years, a steady growth is anticipated in the global barrett’s esophagus with dysplasia treatment market. By 2033, its estimated value will be US$ 7.54 million. Growing public knowledge of the condition and available treatments, along with technological developments that have simplified the diagnosis and management of Barrett’s oesophagus, are the primary factors driving the market. The global market for Barrett’s oesophagus with dysplasia treatment is anticipated to expand at a compound annual growth rate (CAGR) of 5.3% between 2023 and 2033, per a recent industry research analysis released by Future Market Insights.
Barrett’s Esophagus is a condition in which the tissue lining the esophagus is replaced by tissue that is similar to the lining of the intestine. This condition is often a result of long-term acid reflux and can lead to dysplasia, which is the abnormal growth of cells. Dysplasia can be a precursor to esophageal cancer, which makes it important to diagnose and treat Barrett’s Esophagus with Dysplasia as early as possible.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16833
The treatment options for Barrett’s Esophagus with Dysplasia vary depending on the severity of the condition. For patients with low-grade dysplasia, regular monitoring and surveillance is often recommended. For patients with high-grade dysplasia, endoscopic resection and ablation are common treatment options. Other treatment options include surgery, photodynamic therapy, and radiofrequency ablation.
North America is expected to dominate the global market for Barrett’s Esophagus with Dysplasia Treatment during the forecast period. This is due to the high prevalence of Barrett’s Esophagus in the region, as well as the presence of key players in the market. Europe is expected to hold the second-largest market share during the forecast period, followed by the Asia Pacific region.
Key Takeaways:
- From 2018 to 2022, the Barrett’s Esophagus with Dysplasia Treatment market grew at a CAGR of 3.2%.
- The global Barrett’s Esophagus with Dysplasia Treatment market is expected to grow with a 5.3% CAGR from 2023 to 2033.
- As of 2033, the Barrett’s Esophagus with Dysplasia Treatment Market is expected to reach US$ 7.54 Million.
- According to the FMI analysis, the hospitals segment accounts for the largest market share.
- North America is expected to possess 40% market share for the Barrett’s Esophagus with Dysplasia Treatment market.
- The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.
“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Barrett’s esophagus with dysplasia treatment,” says an FMI analyst
Market Competition:
Key players in the market include companies such as Competition Deep Dive, GlaxoSmithKline plc, Novartis AG, Bayer AG, Eli Lilly and Company, Merck & Co., In, AstraZeneca, Johnson & Johnson Private Limited, Cipla Inc., Abbott, AbbVie Inc., along with healthcare providers and technology companies among other global players.
- In August 2022, the American College of Gastroenterology has released new guidelines for Barrett’s esophagus, which suggest expanding the screening methods beyond endoscopic procedures, increasing the frequency of surveillance for short-segment Barrett’s esophagus, and implementing volume criteria for endoscopic therapy centers.
- These guidelines were developed by a team led by Nicholas J. Shaheen, MD, MPH from the University of North Carolina at Chapel Hill, and cover the definition and diagnosis of Barrett’s esophagus, screenings for esophageal adenocarcinoma, surveillance for known Barrett’s esophagus, and medical and endoscopic treatments for Barrett’s esophagus and early neoplasia.
- The authors emphasize that these guidelines should be used as a support for clinical practice and that healthcare providers should take into account patient-specific medical conditions, health status, and preferences to provide patient-centered care.
More Insights Available
FMI, in its new offering, presents an unbiased analysis of the global Barrett’s esophagus with dysplasia treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of type, distribution channel, treatment & region.
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-16833
Key Segments:
Type:
- Low Grade Dysplasia
- High Grade Dysplasia
Treatment:
- Endoscopic Resection
- Radiofrequency Ablation
- Esophagectomy
- Photodynamic Therapy
- Cryotherapy
Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube